Chaida, P; Frimmel, J; Hopfer, L; Gruden, E; Perfler, B; Kailasnathan, A; Bramreiter, B; Folsselteder, J; Wurm, S; Neiss, J; Koeck, S; Wolf, D; Ratzinger, G; Tabrizi-Wizsy, NG; Glebova, K; Rinner, B; Fechter, K; Cisarova, KV; Höfler, G; Kashofer, K; Baldus, C; Stoelzel, F; Heine, A; Woelfler, A; Sill, H; Reinisch, A; Zebisch, A
RAS mutations are frequent in extramedullary AML and drive the tissue infiltration of leukemic cells via the induction of jaml
BLOOD. 2025; 146: 659-660.
Doi: 10.1182/blood-2025-659
[Oral Communication]
Web of Science
FullText
FullText_MUG
Dutta, S; Cisarova, K; Lind, K; Rezania, S; Lyssy, F; Zöscher, F; Vosberg, S; Zebisch, A; Wölfler, A; Pabst, G; Fosselteder, J; Reinisch, A; Sill, H
Mesenchymal stromal cells mediate drug resistance in leukemic cells by modulating their intrinsic inflammation
ANN HEMATOL. 2025; 104(1):S56-S56.-Symposium Proceedings of the international symposium ACUTE LEUKEMIAS XIX (ISALXIX); MAR 16–19, 2025; Munich, GERMANY.
[Poster]
Web of Science